Publications by authors named "Levent Alev"

Claim this Profile
T
The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
Li Yue, Jianing Wang, Hiroyuki Enomoto, Shinji Fujikoshi, Levent Alev

Pain Pract· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Shin-Ichi Konno, Levent Alev, Natsuko Oda, Toshimitsu Ochiai, Hiroyuki Enomoto

Pain Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin.
Hiroyuki Enomoto, Hitoshi Yasuda, Atsushi Nishiyori, Shinji Fujikoshi, Masashi Furukawa, Levent Alev

J Pain Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis.
Yuji Uchio, Hiroyuki Enomoto, Levent Alev, Yuki Kato, Hiroyuki Ishihara

J Pain Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study.
Eiji Harada, Yoichi Satoi, Atsushi Kuga, Hirofumi Tokuoka, Toshiaki Kikuchi, Levent Alev

Neuropsychiatr Dis Treat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia.
Masato Murakami, Kenichi Osada, Hisao Ichibayashi, Hiromichi Mizuno, Toshimitsu Ochiai, Levent Alev

Mod Rheumatol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials.
Levent Alev, Shinji Fujikoshi, Aki Yoshikawa, Hiroyuki Enomoto, Mitsuhiro Ishida

J Pain Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies.
Hiroyuki Enomoto, Shinji Fujikoshi, Jumpei Funai, Nao Sasaki, Michael H Ossipov, Levent Alev

J Pain Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Shinichi Konno, Natsuko Oda, Toshimitsu Ochiai, Levent Alev

Spine (Phila Pa 1976)· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression.
Eiji Harada, Yoichi Satoi, Toshiaki Kikuchi, Koichiro Watanabe, Levent Alev

Neuropsychiatr Dis Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between pain severity and patient-reported outcomes among patients with chronic low back pain in Japan.
William Montgomery, Jeffrey Vietri, Jing Shi, Kei Ogawa, Sawako Kariyasu, Levent Alev

J Pain Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study.
Hitoshi Yasuda, Nigishi Hotta, Masato Kasuga, Atsunori Kashiwagi, Ryuzo Kawamori, Levent Alev

J Diabetes Investig· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
Masato Murakami, Kenichi Osada, Hiromichi Mizuno, Toshimitsu Ochiai, Levent Alev

Arthritis Res Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain.
Kei Ogawa, Shinji Fujikoshi, William Montgomery, Levent Alev

Neuropsychiatr Dis Treat· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of descending inhibitory pathways on chronic pain modulation and clinical implications.
Mikwang Kwon, Murat Altin, Hector Duenas, Levent Alev

Pain Pract· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis